Product Information
ACITRETIN 25 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $3.5896 per EA under NDC 00093113656. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
25 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093113656
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACITRETINApproval Type
Generic (ANDA)
FDA Application
ANDA091455On Market Since
7/19/2013
Pharmacological Classes
Price Statistics
The NADAC for ACITRETIN 25 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 84.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.5896 per EA |
|---|---|
| All-time high | $25.7195 (Jul 16, 2014) |
| All-time low | $3.4171 (Apr 22, 2026) |
| 52-week high | $4.3092 |
| 52-week low | $3.4171 |
| Median price | $10.9892 |
| Average price | $12.7745 |
| Largest weekly change | +62.9% (Oct 18, 2023) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ACITRETIN 25 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ACITRETIN 25 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $3.5896 per EA (NDC 00093113656), effective Jun 24, 2026.
How has the price of ACITRETIN 25 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ACITRETIN 25 MG CAPSULE has declined 84.3%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ACITRETIN 25 MG CAPSULE?
Since Nov 28, 2013, the NADAC for ACITRETIN 25 MG CAPSULE has ranged from a low of $3.4171 (Apr 22, 2026) to a high of $25.7195 (Jul 16, 2014), with a median of $10.9892 per EA.
Are there cheaper alternatives to ACITRETIN 25 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as ACITRETIN 25 MG CAPSULE, but none are currently priced below it.
Who manufactures ACITRETIN 25 MG CAPSULE?
ACITRETIN 25 MG CAPSULE (NDC 00093113656) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification